Schavgoulidze, Anais
35  results:
Search for persons X
?
1

P-362 ID2 acts as a novel tumor suppressor in MM by inhibit..:

Perini, Tommaso ; Yao, Yao ; Ng, Jessica Fong...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S238-S239 , 2023
 
?
3

P-194 Non-coding RNA LINC01410 interacts with the minichrom..:

Gramegna, Doriana ; Liu, Na ; Maisano, Domenico...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S142 , 2023
 
?
4

OAB-016: High risk subclones detected at relapse are presen..:

Lannes, Romain ; Samur, Mehmet ; Perrot, Aurore...
Clinical Lymphoma Myeloma and Leukemia.  22 (2022)  - p. S10 , 2022
 
?
7

Multiple myeloma with hungry plasma cells:

Rieu, Jean‐Baptiste ; Perrot, Aurore ; Vergnolle,, Ines..
British Journal of Haematology.  193 (2021)  3 - p. 443-443 , 2021
 
?
11

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566.  , 2023
 
?
12

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566.  , 2023
 
?
14

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566.  , 2023
 
?
15

Heterogeneity in long-term outcomes for patients with Revis..:

Schavgoulidze, Anais ; Lauwers-Cances, Valérie ; Perrot, Aurore...
info:eu-repo/semantics/altIdentifier/doi/10.3324/haematol.2021.280566.  , 2023
 
1-15